When focusing on CD8+ T cell functional states, we specifically assessed the expression of PD-1, a marker of chronic antigen stimulation and dysfunction that was demonstrated to enrich for tumor-specific T cells across a number of cancers24–27, and TOX, a transcriptional master regulator responsible for terminal T cell dysfunction20. Here, CD8A is linked to neoplasm.